| Current Price | $222.12 | Mkt Cap | $32.6B |
|---|---|---|---|
| Open | $219.79 | P/E Ratio | 37.90 |
| Prev. Close | $222.12 | Div. (Yield) | $1.76 (0.8%) |
| Daily Range | $219.97 - $222.45 | Volume | 413,751 |
| 52-Wk Range | $194.30 - $247.65 | Avg. Daily Vol. | 593,514 |
The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
| Current Price | $222.12 | Mkt Cap | $32.6B |
|---|---|---|---|
| Open | $219.79 | P/E Ratio | 37.90 |
| Prev. Close | $222.12 | Div. (Yield) | $1.76 (0.8%) |
| Daily Range | $219.97 - $222.45 | Volume | 413,751 |
| 52-Wk Range | $194.30 - $247.65 | Avg. Daily Vol. | 593,514 |
The best Bull and Bear pitches based on recency and number of recommendations.
Picked on my 4/19/17 Rule Breaker Investing podcast as as a stock I like for the next three years. Outperform.
I am a Medicare provider of ResMed's line of products and have done so for the past 8 years. Medicare and the other insurers are shrinking the reimbursements to providers of this product (me) as the boomer population increases. Watch for the margins… More
Read the most recent pitches from players about RMD.
Recs
TMFMktmusician
(< 20)
Submitted: 1/20/2022 4:14:45 PM :
Start Price:
$248.52
NYSE:RMD Score:
-3.52
https://www.fool.com/investing/2022/01/20/2-healthcare-stocks-that-could-help-set-you-up-for/
Recs
TMFbonefish
(34.92)
Submitted: 7/27/2021 10:33:32 AM :
Start Price:
$260.64
NYSE:RMD Score:
-12.17
Sleep Apnea and COPD aren't ailments that are going anywhere. In fact, so many are undiagnosed, the market will likely grow much faster than the prevalence of the conditions. Add in a shift to connected devices through software and it seems like ResMed is a great example of how every company is a technology company these days. It's an old school company transforming before our eyes.
Recs
TMFjimhalley
(< 20)
Submitted: 4/12/2021 7:40:48 PM :
Start Price:
$196.23
NYSE:RMD Score:
+9.41
The growth of diagnosis in sleep apnea bodes well for the company. In addition, a lot of sleep apnea diagnoses were put off last year and that will help the company's bottom line this year.
Find the members with the highest scoring picks in RMD.
macchiatto (56.76) Score: +1,087.74
The Score Leader is the player with the highest score across all their picks in RMD.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| macchiatto | 56.76 | 7/17/2008 |
|
3M | $15.42 | +1,340.82% | +253.09% | +1,087.74 | 0 Comment | |
| chipiii3 | < 20 | 6/16/2008 |
|
3W | $16.31 | +1,262.13% | +225.78% | +1,036.35 | 0 Comment | |
| schwah9 | 73.35 | 10/13/2008 |
|
NS | $14.85 | +1,395.94% | +366.78% | +1,029.16 | 0 Comment | |
| AIAbram | < 20 | 8/4/2008 |
|
3W | $16.11 | +1,278.84% | +252.85% | +1,025.99 | 0 Comment | |
| rylin100 | 66.50 | 6/2/2008 |
|
NS | $16.56 | +1,241.25% | +216.75% | +1,024.49 | 0 Comment | |
| raideral | < 20 | 7/2/2008 |
|
1Y | $16.53 | +1,243.99% | +241.80% | +1,002.19 | 0 Comment | |
| alpot | < 20 | 7/2/2008 |
|
1Y | $16.53 | +1,243.99% | +241.80% | +1,002.19 | 0 Comment | |
| kurzzz | 92.28 | 10/23/2008 |
|
1Y | $14.97 | +1,383.51% | +385.31% | +998.20 | 1 Comment | |
| brodie82 | 51.55 | 7/9/2008 |
|
1Y | $16.53 | +1,243.67% | +245.64% | +998.02 | 0 Comment | |
| bcorbett8769 | 46.08 | 7/2/2008 |
|
1Y | $16.55 | +1,241.77% | +244.15% | +997.61 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
